Regeneron Pharmaceuticals Down Over 8%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $673.00, down $64.15 or 8.7%

--Would be lowest close since Sept. 7, 2022, when it closed at $596.44

--On pace for largest percent decrease since March 20, 2020, when it fell 10.49%

--Currently down three of the past five days

--Down 6.72% month-to-date

--Down 6.72% year-to-date

--Down 12.19% from its all-time closing high of $766.39 on Dec. 2, 2022

--Up 8.33% from 52 weeks ago (Jan. 10, 2022), when it closed at $621.27

--Down 12.19% from its 52-week closing high of $766.39 on Dec. 2, 2022

--Up 22.73% from its 52-week closing low of $548.35 on June 14, 2022

--Traded as low as $668.00; lowest intraday level since Sept. 8, 2022, when it hit $652.64

--Down 9.38% at today's intraday low; largest intraday percent decrease since March 20, 2020, when it fell as much as 11.19%

--Worst performer in the S&P 500 today

--Second worst performer in the Nasdaq 100 today

All data as of 10:07:27 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 09, 2023 10:25 ET (15:25 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.